Industry Symposium:
Optimising treatment in poor prognosis early RA
Supported by BMS

 12:30 Impact of antibodies in early RA

  • Pathway to disease progression in the ACPA+ RA patients
  • Clinical presentation incl. imaging
  • Pathology of ACPA+ disease

Philip Conaghan, UK
 12:55 Treating the early rapidly progressing RA patient

  • Clinical trial data
  • Real world data
  • Case studies

Graeme Jones, Australia
13:20 Questions